Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist...

Overview

Journal J Med Chem

Publisher American Chemical Society

Specialty Chemistry

Date 2017 Aug 17

PMID 28813605

Citations 13

Authors

Mark D Ericson

Katie T Freeman

Sathya M Schnell

Katlyn A Fleming

Carrie Haskell-Luevano

Affiliations

Soon will be listed here.

Abstract

The melanocortin system consists of five reported receptors, agonists from the proopiomelanocortin gene transcript, and two antagonists, agouti-signaling protein (ASP) and agouti-related protein (AGRP). For both ASP and AGRP, the hypothesized Arg-Phe-Phe pharmacophores are on exposed β-hairpin loops. In this study, the Asn and Ala positions of a reported AGRP macrocyclic scaffold (c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro]) were explored with 14-compound and 8-compound libraries, respectively, to generate more potent, selective melanocortin receptor antagonists. Substituting diaminopropionic acid (Dap), DDap, and His at the Asn position yielded potent MC4R ligands, while replacing Ala with Ser maintained MC4R potency. Since these substitutions correlate to ASP loop residues, an additional Phe to Ala substitution was synthesized and observed to maintain MC4R potency. Seventeen compounds also possessed inverse agonist activity at the MC5R, the first report of this pharmacology. These findings are useful in developing molecular probes to study negative energy balance conditions and unidentified functions of the MC5R.

Citing Articles

Weirath N, Haskell-Luevano C ACS Pharmacol Transl Sci. 2024; 7(9):2706-2724.

PMID: 39296259 PMC: 11406693. DOI: 10.1021/acsptsci.4c00129.

Incorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic....

Ericson M, Freeman K, Larson C, Bouchard J, John K, Lunzer M ACS Pharmacol Transl Sci. 2024; 7(4):1114-1125.

PMID: 38633589 PMC: 11020072. DOI: 10.1021/acsptsci.4c00011.

Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH] at the MC1R, MC3R, MC4R, and MC5R that Mediates an Increased Feeding Response in Mice and a 40-Fold Selective MC1R Antagonist [Ac-DPhe(pI)-DArg-Nal(2')-Arg-NH].

Ericson M, Tran L, Mathre S, Freeman K, Holdaway K, John K J Med Chem. 2023; 66(12):8103-8117.

PMID: 37307241 PMC: 10631449. DOI: 10.1021/acs.jmedchem.3c00432.

Functional Mixture-Based Positional Scan Identifies a Library of Antagonist Tetrapeptide Sequences (LAtTeS) with Nanomolar Potency for the Melanocortin-4 Receptor and Equipotent with the Endogenous AGRP(86-132) Antagonist.

Ericson M, Doering S, Larson C, Freeman K, Lavoi T, Donow H J Med Chem. 2021; 64(19):14860-14875.

PMID: 34592820 PMC: 8533642. DOI: 10.1021/acs.jmedchem.1c01417.

Peptide late-stage C(sp)-H arylation by native asparagine assistance without exogenous directing groups.

Weng Y, Ding X, Oliveira J, Xu X, Kaplaneris N, Zhu M Chem Sci. 2021; 11(34):9290-9295.

PMID: 34094199 PMC: 8161531. DOI: 10.1039/d0sc03830j.

References

McNulty J, Jackson P, Thompson D, Chai B, Gantz I, Barsh G . Structures of the agouti signaling protein. J Mol Biol. 2005; 346(4):1059-70. DOI: 10.1016/j.jmb.2004.12.030. View

Ericson M, Wilczynski A, Sorensen N, Xiang Z, Haskell-Luevano C . Discovery of a β-Hairpin Octapeptide, c[Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], Mimetic of Agouti-Related Protein(87-132) [AGRP(87-132)] with Equipotent Mouse Melanocortin-4 Receptor (mMC4R) Antagonist Pharmacology. J Med Chem. 2015; 58(11):4638-47. PMC: 5672791. DOI: 10.1021/acs.jmedchem.5b00184. View

Creemers J, Pritchard L, Gyte A, Le Rouzic P, Meulemans S, Wardlaw S . Agouti-related protein is posttranslationally cleaved by proprotein convertase 1 to generate agouti-related protein (AGRP)83-132: interaction between AGRP83-132 and melanocortin receptors cannot be influenced by syndecan-3. Endocrinology. 2005; 147(4):1621-31. DOI: 10.1210/en.2005-1373. View

Klebig M, Wilkinson J, Geisler J, Woychik R . Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci U S A. 1995; 92(11):4728-32. PMC: 41780. DOI: 10.1073/pnas.92.11.4728. View

Miller M, Duhl D, Vrieling H, Cordes S, Ollmann M, Winkes B . Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev. 1993; 7(3):454-67. DOI: 10.1101/gad.7.3.454. View

Lu D, Willard D, Patel I, Kadwell S, Overton L, Kost T . Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature. 1994; 371(6500):799-802. DOI: 10.1038/371799a0. View

Lensing C, Freeman K, Schnell S, Adank D, Speth R, Haskell-Luevano C . An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers. J Med Chem. 2016; 59(7):3112-28. PMC: 5679017. DOI: 10.1021/acs.jmedchem.5b01894. View

Mountjoy K, Mortrud M, Low M, Simerly R, Cone R . Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol. 1994; 8(10):1298-308. DOI: 10.1210/mend.8.10.7854347. View

Butler A, Kesterson R, Khong K, Cullen M, Pelleymounter M, Dekoning J . A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology. 2000; 141(9):3518-21. DOI: 10.1210/endo.141.9.7791. View

10.

Nakanishi S, Inoue A, Kita T, Nakamura M, Chang A, Cohen S . Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor. Nature. 1979; 278(5703):423-7. DOI: 10.1038/278423a0. View

11.

Huszar D, Lynch C, Dunmore J, Fang Q, Berkemeier L, Gu W . Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997; 88(1):131-41. DOI: 10.1016/s0092-8674(00)81865-6. View

12.

Ericson M, Freeman K, Schnell S, Haskell-Luevano C . A Macrocyclic Agouti-Related Protein/[Nle,DPhe]α-Melanocyte Stimulating Hormone Chimeric Scaffold Produces Subnanomolar Melanocortin Receptor Ligands. J Med Chem. 2017; 60(2):805-813. PMC: 5639694. DOI: 10.1021/acs.jmedchem.6b01707. View

13.

Chhajlani V, Wikberg J . Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 1992; 309(3):417-20. DOI: 10.1016/0014-5793(92)80820-7. View

14.

Mountjoy K, Robbins L, Mortrud M, Cone R . The cloning of a family of genes that encode the melanocortin receptors. Science. 1992; 257(5074):1248-51. DOI: 10.1126/science.1325670. View

15.

Ollmann M, Lamoreux M, Wilson B, Barsh G . Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes Dev. 1998; 12(3):316-30. PMC: 316484. DOI: 10.1101/gad.12.3.316. View

16.

Duhl D, Vrieling H, Miller K, Wolff G, Barsh G . Neomorphic agouti mutations in obese yellow mice. Nat Genet. 1994; 8(1):59-65. DOI: 10.1038/ng0994-59. View

17.

Kiefer L, Veal J, Mountjoy K, Wilkison W . Melanocortin receptor binding determinants in the agouti protein. Biochemistry. 1998; 37(4):991-7. DOI: 10.1021/bi971913h. View

18.

Nijenhuis W, Oosterom J, Adan R . AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol. 2001; 15(1):164-71. DOI: 10.1210/mend.15.1.0578. View

19.

Blanchard S, Harris C, Ittoop O, Nichols J, Parks D, Truesdale A . Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line. Biochemistry. 1995; 34(33):10406-11. DOI: 10.1021/bi00033a012. View

20.

Ollmann M, Barsh G . Down-regulation of melanocortin receptor signaling mediated by the amino terminus of Agouti protein in Xenopus melanophores. J Biol Chem. 1999; 274(22):15837-46. DOI: 10.1074/jbc.274.22.15837. View